Skip to content

A comparative study on effect of vomatting & clearing of bowels for treatment purpose in Bronchial Asthma

A comparative study on effect of Vamana & Virechana Karma followed by Brumhana Snehapana (Kantakari Ghrita) in the management of Tamaka Shvasa w.s.r. to Bronchial Asthma

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/01/004330
Enrollment
30
Registered
2014-01-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J452- Mild intermittent asthma Health Condition 2: null- Patients Suffering from Tamaka Shvasa (Bronchial Asthma)

Interventions

Intervention1: Vamana followed by Brumhana with Kantakari Ghrita: Group A Classical Vamana Karma was administered by Ikshvaku Ksheera Yoga in an average dose of 4 gm as per referance of Charak Samhita

Sponsors

IPGTRA Gujrat Ayurved University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having age in between 16 years to 55 years. 2.Disease chronicity up to 10 years. 3.Patients having MRC breathlessness scale up to grade 4. 4.Patients showing moderate obstruction in FEV1%( >35%)&PEFR( >50). were selected for study.

Exclusion criteria

Exclusion criteria: 1.Patients having age less than 16 years and greater than 55 years. 2.Patients having Palmonary Tuberculosis, Ca of lung,lung fibrosis,lung abscess,bronchiectesis, cor-pulmonale,IHD. 3.Patients having any other systemic illness. 4.Patients showing severe obstruction in Lung function tests i.e.FEV% were excluded from study.

Design outcomes

Primary

MeasureTime frame
To assess breathlessness MRC scale was used before and after completion of treatment. It was found that there is marked reduction in breathlessness.Timepoint: At interval of one week up to 6 weeks

Secondary

MeasureTime frame
Lung function test (FEV1%,PEFR) to assess severity of obstruction before and after completion of treatment. There is mild reduction in obstruction.Timepoint: 6 weeks

Countries

India

Contacts

Public ContactDr Shweta Patil

IPGTRA Gujarat Ayurved University

anup_thakar@yahoo.com9427776660

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026